Literature DB >> 17182576

Distinct and shared transcriptomes are regulated by microphthalmia-associated transcription factor isoforms in mast cells.

Amir H Shahlaee1, Stephanie Brandal, Youl-Nam Lee, Chunfa Jie, Clifford M Takemoto.   

Abstract

The Microphthalmia-associated transcription factor (Mitf) is an essential basic helix-loop-helix leucine zipper transcription factor for mast cell development. Mice deficient in Mitf harbor a severe mast cell deficiency, and Mitf-mutant mast cells cultured ex vivo display a number of functional defects. Therefore, an understanding of the genetic program regulated by Mitf may provide important insights into mast cell differentiation. Multiple, distinct isoforms of Mitf have been identified in a variety of cell types; we found that Mitf-a, Mitf-e, and Mitf-mc were the major isoforms expressed in mast cells. To determine the physiologic function of Mitf in mast cells, we restored expression of these isoforms in primary mast cells from Mitf(-/-) mice. We found that these isoforms restored granular morphology and integrin-mediated migration. By microarray analysis, proteases, signaling molecules, cell surface receptor, and transporters comprised the largest groups of genes up-regulated by all isoforms. Furthermore, we found that isoforms also regulated distinct genes sets, suggesting separable biological activities. This work defines the transcriptome regulated by Mitf in mast cells and supports its role as master regulator of mast cell differentiation. Expression of multiple isoforms of this transcription factor may provide for redundancy of biological activities while also allowing diversity of function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17182576      PMCID: PMC2605087          DOI: 10.4049/jimmunol.178.1.378

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice.

Authors:  T Tsujimura; E Morii; M Nozaki; K Hashimoto; Y Moriyama; K Takebayashi; T Kondo; Y Kanakura; Y Kitamura
Journal:  Blood       Date:  1996-08-15       Impact factor: 22.113

2.  Involvement of transcription factor encoded by the mouse mi locus (MITF) in expression of p75 receptor of nerve growth factor in cultured mast cells of mice.

Authors:  T Jippo; E Morii; K Tsujino; T Tsujimura; Y M Lee; D K Kim; H Matsuda; H M Kim; Y Kitamura
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

3.  Systematic method to obtain novel genes that are regulated by mi transcription factor: impaired expression of granzyme B and tryptophan hydroxylase in mi/mi cultured mast cells.

Authors:  A Ito; E Morii; K Maeyama; T Jippo; D K Kim; Y M Lee; H Ogihara; K Hashimoto; Y Kitamura; H Nojima
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

4.  MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes.

Authors:  T J Hemesath; E R Price; C Takemoto; T Badalian; D E Fisher
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

5.  A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.

Authors:  D S Ory; B A Neugeboren; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation.

Authors:  F Y Tsai; S H Orkin
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

7.  Abnormal expression of mouse mast cell protease 5 gene in cultured mast cells derived from mutant mi/mi mice.

Authors:  E Morii; T Jippo; T Tsujimura; K Hashimoto; D K Kim; Y M Lee; H Ogihara; K Tsujino; H M Kim; Y Kitamura
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

8.  Characterization of mouse mast cell protease-8, the first member of a novel subfamily of mouse mast cell serine proteases, distinct from both the classical chymases and tryptases.

Authors:  C Lützelschwab; M R Huang; M C Kullberg; M Aveskogh; L Hellman
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

9.  Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus.

Authors:  E Morii; T Tsujimura; T Jippo; K Hashimoto; K Takebayashi; K Tsujino; S Nomura; M Yamamoto; Y Kitamura
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

10.  Cell type-specific deficiency of c-kit gene expression in mutant mice of mi/mi genotype.

Authors:  K Isozaki; T Tsujimura; S Nomura; E Morii; U Koshimizu; Y Nishimune; Y Kitamura
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

View more
  20 in total

1.  KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.

Authors:  Youl-Nam Lee; Stephanie Brandal; Pierre Noel; Erik Wentzel; Joshua T Mendell; Michael A McDevitt; Reuben Kapur; Melody Carter; Dean D Metcalfe; Clifford M Takemoto
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

Review 2.  Mast cell transcriptional networks.

Authors:  Clifford M Takemoto; Youl-Nam Lee; Anil G Jegga; Daniella Zablocki; Stephanie Brandal; Amir Shahlaee; Suming Huang; Ying Ye; Sivakumar Gowrisankar; Jimmy Huynh; Michael A McDevitt
Journal:  Blood Cells Mol Dis       Date:  2008-04-14       Impact factor: 3.039

Review 3.  Transcriptional determination and functional specificity of myeloid cells: making sense of diversity.

Authors:  Silvia Monticelli; Gioacchino Natoli
Journal:  Nat Rev Immunol       Date:  2017-06-05       Impact factor: 53.106

4.  The naive airway hyperresponsiveness of the A/J mouse is Kit-mediated.

Authors:  Emily Cozzi; Kate G Ackerman; Anders Lundequist; Jeffrey M Drazen; Joshua A Boyce; David R Beier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

5.  Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway.

Authors:  Lakshmi Reddy Palam; Raghuveer Singh Mali; Baskar Ramdas; Sridhar Nonavinkere Srivatsan; Valeria Visconte; Ramon V Tiu; Bart Vanhaesebroeck; Axel Roers; Alexander Gerbaulet; Mingjiang Xu; Sarath Chandra Janga; Clifford M Takemoto; Sophie Paczesny; Reuben Kapur
Journal:  JCI Insight       Date:  2018-02-22

6.  Balanced interactions between Lyn, the p85alpha regulatory subunit of class I(A) phosphatidylinositol-3-kinase, and SHIP are essential for mast cell growth and maturation.

Authors:  Peilin Ma; Sasidhar Vemula; Veerendra Munugalavadla; Jinbiao Chen; Emily Sims; Jovencio Borneo; Takako Kondo; Baskar Ramdas; Raghuveer Singh Mali; Shuo Li; Eri Hashino; Clifford Takemoto; Reuben Kapur
Journal:  Mol Cell Biol       Date:  2011-07-26       Impact factor: 4.272

7.  The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor.

Authors:  Peilin Ma; Raghuveer Singh Mali; Veerendra Munugalavadla; Subha Krishnan; Baskar Ramdas; Emily Sims; Holly Martin; Joydeep Ghosh; Shuo Li; Rebecca J Chan; Gerald Krystal; Andrew W Craig; Clifford Takemoto; Reuben Kapur
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

8.  MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.

Authors:  Gaurav Mehta; Sivarajan Kumarasamy; Jian Wu; Aaron Walsh; Lijun Liu; Kandace Williams; Bina Joe; Ivana L de la Serna
Journal:  J Mol Cell Cardiol       Date:  2015-09-24       Impact factor: 5.000

Review 9.  Transcriptional regulation of mast cell and basophil lineage commitment.

Authors:  Hua Huang; Yapeng Li; Bing Liu
Journal:  Semin Immunopathol       Date:  2016-04-28       Impact factor: 9.623

10.  Alternative promoter use in eye development: the complex role and regulation of the transcription factor MITF.

Authors:  Kapil Bharti; Wenfang Liu; Tamas Csermely; Stefano Bertuzzi; Heinz Arnheiter
Journal:  Development       Date:  2008-02-13       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.